← Eichor
Study identifier: NCT05439161 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

XEN Glaucoma Gel Stent Versus Trabeculectomy

Condition: Primary Open Angle Glaucoma · Pseudoexfoliation Glaucoma · Pigmentary Dispersion Glaucoma  ·  Sponsor: Prof. Dr. Herbert Reitsamer

PhaseNA
Planned participants196
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

Multicentric evaluation of best corrected visual acuity of the XEN implant versus classic trabeculectomy in open angle glaucoma subjects

This description comes directly from the study's public registry record.

Talk to the study team

Markus Lenzhofer, MD PhD  ·  +43 5 7255  ·  m.lenzhofer@salk.at

Herbert Reitsamer, MD  ·  +43 5 7255  ·  h.reitsamer@salk.at

Always discuss trial participation with your own doctor first.

Locations (1)

Dept. Ophthalmology and Optometry Paracelsus Medical UniversitySalzburg, AustriaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05439161